Association of anti-IL-12/23 biologic agents ustekinumab and briakinumab with major adverse cardiovascular events

作者:Tzellos T; Kyrgidis A; Trigoni A; Zouboulis C C*
来源:Journal of the European Academy of Dermatology and Venereology, 2013, 27(12): 1586-1587.
DOI:10.1111/jdv.12126